US calls for DOJ investigation of Hims over GLP-1 drugs
The US government said it will refer telehealth and GLP-1 company Hims & Hers to the Department of Justice for investigation, following the company's controversial launch of a compounded version of Novo ...
⚠️ 风险分析 中
摘要：美国司法部将对远程医疗公司Hims & Hers就GLP-1药物展开调查。
影响：在美经营的医药及远程医疗企业面临更严格的合规审查，可能影响业务拓展和产品上市。
建议：加强药品合规审查，关注美国监管动态，评估供应链与法律风险。
「素履以往」
Not the sharpest mind, but the steadiest hand.
Not the sharpest mind, but the steadiest hand.